221 related articles for article (PubMed ID: 19190080)
1. Resistance to chemotherapy and hormone therapy in endometrial cancer.
Chaudhry P; Asselin E
Endocr Relat Cancer; 2009 Jun; 16(2):363-80. PubMed ID: 19190080
[TBL] [Abstract][Full Text] [Related]
2. Old and new perspectives in the pharmacological treatment of advanced or recurrent endometrial cancer: Hormonal therapy, chemotherapy and molecularly targeted therapies.
Gadducci A; Cosio S; Genazzani AR
Crit Rev Oncol Hematol; 2006 Jun; 58(3):242-56. PubMed ID: 16436330
[TBL] [Abstract][Full Text] [Related]
3. Systemic therapy in metastatic or recurrent endometrial cancer.
Pectasides D; Pectasides E; Economopoulos T
Cancer Treat Rev; 2007 Apr; 33(2):177-90. PubMed ID: 17196749
[TBL] [Abstract][Full Text] [Related]
4. Hormonal therapy of endometrial stromal sarcoma.
Reich O; Regauer S
Curr Opin Oncol; 2007 Jul; 19(4):347-52. PubMed ID: 17545798
[TBL] [Abstract][Full Text] [Related]
5. Pharmacotherapy of endometrial cancer.
Barrena Medel NI; Bansal S; Miller DS; Wright JD; Herzog TJ
Expert Opin Pharmacother; 2009 Aug; 10(12):1939-51. PubMed ID: 19586421
[TBL] [Abstract][Full Text] [Related]
6. [Hormone therapy of endometrial carcinoma].
Kuramoto H; Jobo T; Kato Y; Tateoka K; Sato R
Gan To Kagaku Ryoho; 1996 May; 23(6):673-7. PubMed ID: 8645016
[TBL] [Abstract][Full Text] [Related]
7. Progestin therapy for endometrial cancer: the potential of fourth-generation progestin (review).
Banno K; Kisu I; Yanokura M; Tsuji K; Masuda K; Ueki A; Kobayashi Y; Yamagami W; Nomura H; Susumu N; Aoki D
Int J Oncol; 2012 Jun; 40(6):1755-62. PubMed ID: 22366992
[TBL] [Abstract][Full Text] [Related]
8. Hormonal treatment of endometrial carcinoma.
Baekelandt M
Expert Rev Anticancer Ther; 2002 Feb; 2(1):106-12. PubMed ID: 12113059
[TBL] [Abstract][Full Text] [Related]
9. Targeting apoptosis as an approach for gastrointestinal cancer therapy.
Qiao L; Wong BC
Drug Resist Updat; 2009 Jun; 12(3):55-64. PubMed ID: 19278896
[TBL] [Abstract][Full Text] [Related]
10. Hormonal therapy of endometrial cancer.
Markman M
Eur J Cancer; 2005 Mar; 41(5):673-5. PubMed ID: 15763641
[TBL] [Abstract][Full Text] [Related]
11. Cell signaling in endometrial carcinoma: phosphorylated 4E-binding protein-1 expression in endometrial cancer correlates with aggressive tumors and prognosis.
Castellvi J; Garcia A; Ruiz-Marcellan C; Hernández-Losa J; Peg V; Salcedo M; Gil-Moreno A; Ramon y Cajal S
Hum Pathol; 2009 Oct; 40(10):1418-26. PubMed ID: 19428047
[TBL] [Abstract][Full Text] [Related]
12. Longstanding survival without cancer progression in a patient affected by endometrial carcinoma treated primarily with leuprolide.
Noci I; Borri P; Bonfirraro G; Chieffi O; Arcangeli A; Cherubini A; Dabizzi S; Buccoliero AM; Paglierani M; Taddei GL
Br J Cancer; 2001 Aug; 85(3):333-6. PubMed ID: 11487260
[TBL] [Abstract][Full Text] [Related]
13. Is overcoming hormone resistance in breast cancer possible?
Orphanos G; Kakoullou N; Ardavanis A
J BUON; 2008; 13(3):315-22. PubMed ID: 18979544
[TBL] [Abstract][Full Text] [Related]
14. Fertility-sparing therapy for young women with endometrial cancer.
Frumovitz M; Gershenson DM
Expert Rev Anticancer Ther; 2006 Jan; 6(1):27-32. PubMed ID: 16375641
[TBL] [Abstract][Full Text] [Related]
15. Hormonal carcinogenesis and socio-biological development factors in endometrial cancer: a clinical review.
Tinelli A; Vergara D; Martignago R; Leo G; Malvasi A; Tinelli R
Acta Obstet Gynecol Scand; 2008; 87(11):1101-13. PubMed ID: 18607816
[TBL] [Abstract][Full Text] [Related]
16. A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer.
Secord AA; Havrilesky LJ; O'Malley DM; Bae-Jump V; Fleming ND; Broadwater G; Cohn DE; Gehrig PA
Gynecol Oncol; 2009 Sep; 114(3):442-7. PubMed ID: 19560193
[TBL] [Abstract][Full Text] [Related]
17. Gonadotropin-releasing hormone type II induces apoptosis of human endometrial cancer cells by activating GADD45alpha.
Wu HM; Cheng JC; Wang HS; Huang HY; MacCalman CD; Leung PC
Cancer Res; 2009 May; 69(10):4202-8. PubMed ID: 19366794
[TBL] [Abstract][Full Text] [Related]
18. Management of early-stage endometrial cancer.
Lu KH
Semin Oncol; 2009 Apr; 36(2):137-44. PubMed ID: 19332248
[TBL] [Abstract][Full Text] [Related]
19. Proteomic approach to ETV5 during endometrial carcinoma invasion reveals a link to oxidative stress.
Monge M; Colas E; Doll A; Gil-Moreno A; Castellvi J; Diaz B; Gonzalez M; Lopez-Lopez R; Xercavins J; Carreras R; Alameda F; Canals F; Gabrielli F; Reventos J; Abal M
Carcinogenesis; 2009 Aug; 30(8):1288-97. PubMed ID: 19443906
[TBL] [Abstract][Full Text] [Related]
20. Targeting molecular pathways in endometrial cancer: a focus on the FGFR pathway.
Lee PS; Secord AA
Cancer Treat Rev; 2014 May; 40(4):507-12. PubMed ID: 24332498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]